MTOR and endometrial cancer: The immunohistochemical expression of commonly studied biomarkers in endometrial cancer window studies, including Ki-67, phosphorylated markers of the PI3K-Akt-mTOR and insulin signaling pathways and hormone receptors, is significantly lower in the hysterectomy specimen compared with an endometrial biopsy taken immediately prior to the commencement of surgery.